"IRIB CNR Istituto per la Ricerca e l'Innovazione Biomedica Consiglio Nazionale delle Ricerche"

During the past decade, Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council" #1 collaborator was "Campus Bio-Medico University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council" are "Asthma" (10 trials), "Allergic Rhinitis" (8 trials), "Healthy" (2 trials), "Cardiovascular Diseases" (1 trials) and "Respiratory Disease" (1 trials). Many other conditions were trialed in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council" in a lesser frequency.

Most popular intervention types in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council" are "Other" (8 trials), "Drug" (5 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Assessment of E-nose measurements" (1 trials), "Budesonide nasal spray (100 mcg bid)" (1 trials), "Budesonide nasal spray (50 mcg bid" (1 trials), "CARATKids Questionnaire" (1 trials) and "CERCHIO 10 mg/ml OS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".